Grants per year
Personal profile
Education/Academic qualification
PHD
… → 1983
MA
… → 1979
BA
… → 1975
Fingerprint
Dive into the research topics where Michael Smith is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Finished
-
Toluca Valley Geochemical Variation Project (ASUF 30007626)
8/1/17 → 12/31/17
Project: Research project
-
Heritage sites, climate change, and urban science
Smith, M. E. & Ortman, S. G., Jan 2023, In: Urban Climate. 47, 101371.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
How can research on past urban adaptations be made useful for sustainability science?
Smith, M. E., Feb 7 2023, In: Global Sustainability. 6, e4.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Urban Success and Urban Adaptation over the Long Run
Smith, M. E., Jan 1 2023, In: Open Archaeology. 9, 1, 20220285.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Scaling of Hunter-Gatherer Camp Size and Human Sociality
Whitelaw, T., Bettencourt, L. M. A., Wiessner, P., Smith, M. E. & Ortman, S., Feb 2022, In: Current anthropology. 63, 1, p. 68-94 27 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Ancient Egyptian Urbanism in a comparative, global context
Smith, M. E., 2021, In: Journal of Egyptian History. 13, 1, p. 77-100 24 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations
Press/Media
-
Monthly: Xenon Pharmaceuticals (XENE: $31.0) drops 6% on high volatility in October 2023
11/6/23
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Xenon Pharmaceuticals (XENE: $32.99) gains 6.9% on firm volume; +$2.12 [6.9%] Vol Index 1.3 [1 is avg]
11/4/23
1 item of Media coverage
Press/Media: Press / Media
-
Monthly: Xenon Pharmaceuticals (XENE: $31.0) drops 6% on high volatility in October 2023
11/1/23
1 item of Media coverage
Press/Media: Press / Media
-
-
Monthly: Xenon Pharmaceuticals (XENE: $31.0) drops 6% on high volatility in October 2023
10/31/23
1 item of Media coverage
Press/Media: Press / Media